DLBCL
Clinical trials for DLBCL explained in plain language.
Never miss a new study
Get alerted when new DLBCL trials appear
Sign up with your email to follow new studies for DLBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: scientists test Next-Gen cell therapy
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy for adults with B-cell lymphoma that has come back or hasn't responded to standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look for early signs that the t…
Matched conditions: DLBCL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Could your gut bugs predict cancer treatment success?
Knowledge-focused Not yet recruitingThis study aims to understand if the types of bacteria in a patient's gut (the microbiome) influence how well they respond to a lymphoma drug called glofitamab. Researchers will observe 30 patients with a specific type of lymphoma (DLBCL) who are already scheduled to receive this…
Matched conditions: DLBCL
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC